Technical Specifications
| Product Name | CJC-1295 (w/o DAC) + Ipamorelin Blend |
|---|---|
| Product Type | Dual-component lyophilized peptide blend |
| Blend Ratio | Verify against CoA (typically 1:1 or 2:1 CJC:IPA by mass) |
| Total Quantity per Vial | 10 mg (combined) |
| Purity (Each Component) | ≥98% (HPLC) |
| Form | Co-lyophilized powder |
| Component 1 | CJC-1295 w/o DAC (Modified GRF 1-29) |
| CJC-1295 Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ |
| CJC-1295 Residues | 29 amino acids |
| CJC-1295 MW | 3,367.97 g/mol |
| CJC-1295 CAS | 863288-34-0 |
| Component 2 | Ipamorelin |
| Ipamorelin Sequence | Aib-His-D-2Nal-D-Phe-Lys-NH₂ |
| Ipamorelin Residues | 5 amino acids (pentapeptide) |
| Ipamorelin MW | 711.85 g/mol |
| Ipamorelin CAS | 170851-70-4 |
| Appearance | White to off-white powder |
| ] | |
| Storage | –20°C or below |
| Stability | 24 months (if stored as directed) |
